Clinical trial

Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI

NCT02794402

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-01

PhasePHASE2

Study timeline

Study start (actual)2015-09-01Date precision: month

Registry last updated2022-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

PlaceboBEHAVIORAL

Sponsors & collaborators

Uppsala Universitylead sponsor

Mapped research locations

UppsalaSweden1 SalzburgAustria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02794402 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.